SELLAS Trademark

Trademark Overview

On Sunday, January 3, 2016, a trademark application was filed for SELLAS with the United States Patent and Trademark Office. The USPTO has given the SELLAS trademark a serial number of 86863987. The federal status of this trademark filing is REGISTERED as of Tuesday, February 18, 2020. This trademark is owned by Sellas Life Sciences Group AG. The SELLAS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and biopharmaceutical preparations for the treatment of cancer and central nervous system (CNS) disorders

Scientific research and development for medical, pharmaceutical, and biopharmaceutical purposes; consulting in the field of medical, pharmaceutical, and biopharmaceutical research and product development; conducting of clinical trials, for others and development of pharmaceutical products, biopharmaceutical products, and other therapeutic products; development of cancer vaccines, and treatment products for cancer and central nervous system (CNS) disorders
sellas

General Information

Serial Number86863987
Word MarkSELLAS
Filing DateSunday, January 3, 2016
Status700 - REGISTERED
Status DateTuesday, February 18, 2020
Registration Number5991389
Registration DateTuesday, February 18, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 6, 2016

Trademark Statements

Goods and ServicesPharmaceutical and biopharmaceutical preparations for the treatment of cancer and central nervous system (CNS) disorders
Translation of Words in MarkThe English translation of the word "SELLAS" in the mark is "STAMP" or "SEAL".
Goods and ServicesScientific research and development for medical, pharmaceutical, and biopharmaceutical purposes; consulting in the field of medical, pharmaceutical, and biopharmaceutical research and product development; conducting of clinical trials, for others and development of pharmaceutical products, biopharmaceutical products, and other therapeutic products; development of cancer vaccines, and treatment products for cancer and central nervous system (CNS) disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 19, 2016
Primary Code005
First Use Anywhere DateMonday, December 9, 2019
First Use In Commerce DateMonday, December 9, 2019
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 12, 2016
Primary Code042
First Use Anywhere DateThursday, August 31, 2017
First Use In Commerce DateThursday, August 31, 2017

Trademark Owner History

Party NameSLSG LIMITED LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressDOVER, DE 19901
Party NameSLSG LIMITED LLC
Party Type22 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressDOVER, DE 19901
Party NameSELLAS LIFE SCIENCES GROUP LTD.
Party Type21 - New Owner After Publication
Legal Entity Type11 - Company
AddressHAMILTON HM 11
BM
Party NameSellas Life Sciences Group AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressZug CH-6300
CH
Party NameSellas Life Sciences Group AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressZug CH-6300
CH

Trademark Events

Event DateEvent Description
Thursday, October 6, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 6, 2016NEW APPLICATION ENTERED
Tuesday, January 12, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 19, 2016ASSIGNED TO EXAMINER
Monday, April 25, 2016NON-FINAL ACTION WRITTEN
Monday, April 25, 2016NON-FINAL ACTION E-MAILED
Monday, April 25, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 23, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, October 2, 2016ASSIGNED TO LIE
Thursday, October 6, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 6, 2016PUBLISHED FOR OPPOSITION
Tuesday, January 31, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 26, 2016EXAMINERS AMENDMENT -WRITTEN
Wednesday, October 26, 2016EXAMINERS AMENDMENT E-MAILED
Wednesday, October 26, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, October 26, 2016EXAMINER'S AMENDMENT ENTERED
Wednesday, October 26, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 3, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 16, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 6, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, January 25, 2018SOU EXTENSION 2 FILED
Thursday, January 25, 2018SOU EXTENSION 2 GRANTED
Saturday, January 27, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 27, 2018SOU TEAS EXTENSION RECEIVED
Friday, July 27, 2018SOU EXTENSION 3 FILED
Thursday, July 13, 2017SOU TEAS EXTENSION RECEIVED
Thursday, July 13, 2017SOU EXTENSION 1 FILED
Thursday, July 13, 2017SOU EXTENSION 1 GRANTED
Saturday, July 15, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 19, 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, January 25, 2018SOU TEAS EXTENSION RECEIVED
Friday, July 27, 2018SOU EXTENSION 3 GRANTED
Wednesday, July 24, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, July 31, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 28, 2019SOU TEAS EXTENSION RECEIVED
Monday, January 28, 2019SOU EXTENSION 4 FILED
Monday, January 28, 2019SOU EXTENSION 4 GRANTED
Wednesday, January 30, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 10, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, July 24, 2019SOU EXTENSION 5 FILED
Monday, July 29, 2019SOU EXTENSION 5 GRANTED
Tuesday, July 30, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 29, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 12, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 12, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 18, 2019TEAS STATEMENT OF USE RECEIVED
Wednesday, December 18, 2019USE AMENDMENT FILED
Saturday, December 28, 2019STATEMENT OF USE PROCESSING COMPLETE
Tuesday, January 14, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, January 15, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 18, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, February 18, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

sellas development products pharmaceutical biopharmaceutical cancer research disorders medical system central